Suzhou Ersheng Biopharmaceutical was established in December 2021 and is located in the beautiful Suzhou Industrial Park Biobay. The company has achieved many breakthrough innovations in the field of drug delivery, and has developed a new generation of tumor nanovaccines based on whole cell components of cancer cells, cancer specific T cell detection technology, and mRNA vaccine delivery technology on this basis. The company's mission is to help conquer the last mile of cancer and accelerate the 100 meter run. It focuses on the research and development of innovative drugs, treatment methods, and detection technologies, hoping to become an outstanding enterprise in the global cancer treatment and drug delivery field.
